BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17620751)

  • 1. Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives.
    Greco DB; Simão M
    AIDS; 2007 Jul; 21 Suppl 4():S37-45. PubMed ID: 17620751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
    Nunn AS; Fonseca EM; Bastos FI; Gruskin S; Salomon JA
    PLoS Med; 2007 Nov; 4(11):e305. PubMed ID: 18001145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.
    Ford N; Wilson D; Costa Chaves G; Lotrowska M; Kijtiwatchakul K
    AIDS; 2007 Jul; 21 Suppl 4():S21-9. PubMed ID: 17620749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brazil and access to HIV/AIDS drugs: a question of human rights and public health.
    Galvão J
    Am J Public Health; 2005 Jul; 95(7):1110-6. PubMed ID: 15933238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sustainability of Brazilian policy for access to antiretroviral drugs].
    Grangeiro A; Teixeira L; Bastos FI; Teixeira P
    Rev Saude Publica; 2006 Apr; 40 Suppl():60-9. PubMed ID: 16729160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral treatment in resource-poor settings: the Brazilian experience.
    Teixeira PR; Vitória MA; Barcarolo J
    AIDS; 2004 Jun; 18 Suppl 3():S5-7. PubMed ID: 15322477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. We are all people living with AIDS: myths and realities of AIDS in Brazil.
    Daniel H
    Int J Health Serv; 1991; 21(3):539-51. PubMed ID: 1917212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to antiretroviral drugs in Brazil.
    Galvão J
    Lancet; 2002 Dec; 360(9348):1862-5. PubMed ID: 12480377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.
    Venkatesh KK; Mayer KH; Carpenter CC
    Health Aff (Millwood); 2012 Jul; 31(7):1429-38. PubMed ID: 22778332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?
    Meiners C; Sagaon-Teyssier L; Hasenclever L; Moatti JP
    PLoS One; 2011; 6(8):e23478. PubMed ID: 21858138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The (political) economics of antiretroviral treatment in developing countries.
    Nattrass NJ
    Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to antiretroviral treatment in Latin American countries and the Caribbean.
    Chequer P; Cuchí P; Mazin R; García Calleja JM
    AIDS; 2002 Dec; 16 Suppl 3():S50-7. PubMed ID: 12685925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global patent police block cost-reduction efforts.
    Kasper T
    GMHC Treat Issues; 1999 Mar; 13(3):1-2. PubMed ID: 11366201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The affordability of antiretroviral therapy in developing countries: what policymakers need to know.
    Forsythe SS
    AIDS; 1998; 12 Suppl 2():S11-8. PubMed ID: 9792357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affordable access to essential medication in developing countries: conflicts between ethical and economic imperatives.
    Schüklenk U; Ashcroft RE
    J Med Philos; 2002 Apr; 27(2):179-95. PubMed ID: 11961696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to antiretroviral drugs and AIDS management in Senegal.
    Desclaux A; Ciss M; Taverne B; Sow PS; Egrot M; Faye MA; Lanièce I; Sylla O; Delaporte E; Ndoye I
    AIDS; 2003 Jul; 17 Suppl 3():S95-101. PubMed ID: 14565615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract]   [Full Text] [Related]  

  • 18. [Brazilian policy for the distribution and production of antiretroviral drugs: a privilege or a right?].
    Galvao J
    Cad Saude Publica; 2002; 18(1):213-9. PubMed ID: 11910440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
    Benzaken AS; Pereira GFM; Costa L; Tanuri A; Santos AF; Soares MA
    AIDS Res Ther; 2019 Aug; 16(1):19. PubMed ID: 31412889
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.